Beauty Health Co
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
SKIN$16.77+6.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
Item 1. Financial Statements.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except for share amounts)
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash, cash equivalents, and restricted cash | $349,544 | $523,025 |
| Accounts receivable, net of allowances for estimated credit losses of $8,257 and $6,604 at June 30, 2024 and December 31, 2023, respectively | 41,409 | 54,697 |
| Inventories | 77,143 | 91,321 |
| Income tax receivable | 401 | 332 |
| Prepaid expenses and other current assets | 21,129 | 28,877 |
| Total current assets | 489,626 | 698,252 |
| Property and equipment, net | 9,718 | 14,226 |
| Right-of-use assets, net | 14,942 | 12,120 |
| Intangible assets, net | 54,161 | 62,123 |
| Goodwill | 124,822 | 125,818 |
| Deferred income tax assets, net | 3,035 | 531 |
| Other assets | 15,529 | 16,043 |
| TOTAL ASSETS | $711,833 | $929,113 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $26,686 | $44,768 |
| Accrued payroll-related expenses | 17,146 | 22,028 |
| Lease liabilities, current | 4,278 | 4,598 |
| Income tax payable | 2,360 | 2,759 |
| Syndeo Program reserves | 912 | 21,009 |
| Other accrued expenses | 24,044 | 19,846 |
| Total current liabilities | 75,426 | 115,008 |
| Lease liabilities, non-current | 12,704 | 9,319 |
| Deferred income tax liabilities, net | 1,064 | 702 |
| Warrant liabilities | 976 | 3,555 |
| Convertible senior notes, net | 550,625 | 738,372 |
| Other long-term liabilities | 1,849 | 2,767 |
| Total liabilities | 642,644 | 869,723 |
| Commitments (Note 10) | ||
| Stockholders’ equity: | ||
| Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 123,993,785 and 122,899,002 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively | 12 | 12 |
| Additional paid-in capital | 553,420 | 541,281 |
| Accumulated other comprehensive loss | (4,899) | (3,036) |
| Accumulated deficit | (479,344) | (478,867) |
| Total stockholders’ equity | 69,189 | 59,390 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $711,833 | $929,113 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.